Dallas Research Center prides itself on conducting FDA-regulated trials. We are competent in the performance of phase II, III and IV studies for investigation medication and devices. Also, Dallas Research Center is experienced in the development of investigator-initiated trials. All FDA-regulated clinical trials are conducted according to the Good Clinical Practice (GCP) guidelines and the principles contained in the World Medical Association Declaration of Helsinki on the ‘Ethical Principles for Medical Research Involving Human Subjects’ (2001) as well as SCR’s standard operating procedures (SOP’s).
The Dallas Research Center team is highly trained with years of experience and is committed to ensuring both the integrity of the protocol and the rights and privacy of each patient are protected. Our staff includes full-time clinical research coordinators dedicated to the execution of clinical trials with a proven track record of meeting or exceeding enrollment goals in studies in which we participate. Complementing our research staff is a team of board-certified dermatologists and research coordinators.
Our facilities have multiple examination rooms, laboratory facilities, and temperature-controlled limited access investigational product (IP) storage areas.
The sites have designated secure office areas for administration, coordinators, regulatory and CRA/Monitors. These offices have access to a high-speed internet connection, telephones, printers and copiers as well as a document scanner and facsimile.
Our success and attention to detail are a significant factor as to why many leading pharmaceutical companies have chosen Dallas Research Center for their clinical studies over the past 13 years.